MYCN and neuroblastoma: To determine whether this impaired growth in MYCN-amplified neuroblastoma is linked to cell cycle perturbations, we used an 5-ethynyl-2′-deoxyuridine (EdU) and propidium iodide (PI) incorporation assay to assess progression through the cell cycle.